APA

Boyé P., Floch F., Serres F., Segaoula Z., Hordeaux J., Pascal Q., Coste V., Courapied S., Bouchaert E., Rybicka A., Mazuy C., Marescaux L., Geeraert K., Fournel-Fleury C., Duhamel A., Machuron F., Ferré P., Pétain A., Guilbaud N., Tierny D. & Gomes B. (2020). Randomized, double-blind trial of F14512, a polyamine-vectorized anticancer drug, compared with etoposide phosphate, in dogs with naturally occurring lymphoma. : Oncotarget.

Chicago

Boyé Pierre, Floch Franck, Serres François, Segaoula Zacharie, Hordeaux Juliette, Pascal Quentin, Coste Virginie, Courapied Sandy, Bouchaert Emmanuel, Rybicka Agata, Mazuy Claire, Marescaux Laurent, Geeraert Kévyn, Fournel-Fleury Corinne, Duhamel Alain, Machuron François, Ferré Pierre, Pétain Aurélie, Guilbaud Nicolas, Tierny Dominique and Gomes Bruno. 2020. Randomized, double-blind trial of F14512, a polyamine-vectorized anticancer drug, compared with etoposide phosphate, in dogs with naturally occurring lymphoma. : Oncotarget.

Harvard

Boyé P., Floch F., Serres F., Segaoula Z., Hordeaux J., Pascal Q., Coste V., Courapied S., Bouchaert E., Rybicka A., Mazuy C., Marescaux L., Geeraert K., Fournel-Fleury C., Duhamel A., Machuron F., Ferré P., Pétain A., Guilbaud N., Tierny D. and Gomes B. (2020). Randomized, double-blind trial of F14512, a polyamine-vectorized anticancer drug, compared with etoposide phosphate, in dogs with naturally occurring lymphoma. : Oncotarget.

MLA

Boyé Pierre, Floch Franck, Serres François, Segaoula Zacharie, Hordeaux Juliette, Pascal Quentin, Coste Virginie, Courapied Sandy, Bouchaert Emmanuel, Rybicka Agata, Mazuy Claire, Marescaux Laurent, Geeraert Kévyn, Fournel-Fleury Corinne, Duhamel Alain, Machuron François, Ferré Pierre, Pétain Aurélie, Guilbaud Nicolas, Tierny Dominique and Gomes Bruno. Randomized, double-blind trial of F14512, a polyamine-vectorized anticancer drug, compared with etoposide phosphate, in dogs with naturally occurring lymphoma. : Oncotarget. 2020.